What is the recommended treatment for impetigo?

Treatment of Impetigo

For localized impetigo with limited lesions, topical mupirocin or retapamulin ointment applied twice daily is the recommended first-line treatment, while oral antibiotics (cephalexin or dicloxacillin) should be reserved for widespread disease or when topical therapy fails. 1

Treatment Selection Algorithm

Step 1: Assess Disease Extent

Limited disease (localized impetigo):

• Topical antibiotics are equally or more effective than oral therapy 2
• Mupirocin ointment 2% applied twice daily 1
• Retapamulin ointment 1% applied twice daily 1
• Both topical agents demonstrate superior cure rates compared to placebo (RR 2.24,95% CI 1.61-3.13) 2

Widespread disease or multiple lesions:

• Systemic therapy is preferred to decrease transmission 1
• Oral antibiotics should target both S. aureus and Streptococcus pyogenes unless cultures confirm streptococci alone 1

Step 2: Select Appropriate Oral Antibiotic

First-line oral options for methicillin-susceptible infections:

• Cephalexin 250 mg four times daily (adults) or 25-50 mg/kg/day divided in 3-4 doses (children) 1
• Dicloxacillin 250 mg four times daily (adults) 1
• These penicillinase-resistant agents are effective as most staphylococcal isolates remain methicillin-susceptible 1

Penicillin-allergic patients or MRSA suspected:

• Clindamycin 300-400 mg four times daily (adults) or 20 mg/kg/day in 3 divided doses (children) 1
• Doxycycline 100 mg twice daily (not for children <8 years) 1
• Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily (adults) or 8-12 mg/kg/day based on trimethoprim component (children) 1

Step 3: Consider Antibiotic Resistance Patterns

Critical caveat: Topical mupirocin demonstrated slight superiority over oral erythromycin (RR 1.07,95% CI 1.01-1.13) in pooled analysis 2. However, erythromycin resistance is increasingly common, and some strains of S. aureus and S. pyogenes show resistance to macrolides 1.

Penicillin is inferior to other options:

• Penicillin showed worse outcomes compared to erythromycin (RR 1.29,95% CI 1.07-1.56) and cloxacillin (RR 1.59,95% CI 1.21-2.08) 2
• Should only be used when cultures confirm streptococci alone 1

Step 4: Duration and Monitoring

Treatment duration:

• Topical therapy: Continue until lesions resolve, typically 5-7 days 1
• Oral therapy: Standard course is 7-10 days, though specific duration varies by agent 1

Side effects:

• Oral antibiotics cause more adverse effects than topical treatment, predominantly gastrointestinal symptoms 2
• Reported side effects are generally mild overall 2

Special Considerations

Topical mupirocin versus fusidic acid:

• These agents show equivalent efficacy (RR 1.03,95% CI 0.95-1.11) 2
• Choice depends on local availability and resistance patterns 3, 4

Antiseptic solutions:

• Lack robust evidence for efficacy 1
• Topical antibiotics demonstrated superiority over disinfecting treatments (RR 1.15,95% CI 1.01-1.32) 2

Culture recommendations:

• Cultures of vesicle fluid, pus, or erosions establish the causative organism 1
• Particularly important when MRSA is suspected or in treatment failures 1

Antimicrobial stewardship:

• Growing bacterial resistance to commonly used antibiotics necessitates judicious antibiotic use 3, 4, 2
• Newer agents like ozenoxacin and retapamulin show activity against MRSA with lower reported resistance 3
• Healthcare providers should be aware of local resistance patterns when selecting therapy 4